Cytokine-dependent production of nitric oxide (NO) by rat cardiac myocytes is a consequence of increased expression of the inducible isoform of nitric oxide synthase (iNOS or NOS2) and, in the presence of insulin, depresses the contractile function of these cells in vivo and in vitro. Experiments reported here show that Llysine, a competitive antagonist of L-arginine uptake, suppressed NO production (detected as nitrite accumulation) by interleukin (IL)-1 and interferon (IFN) ␥-pretreated cardiac myocytes by 70%, demonstrating that NO production is dependent on L-arginine uptake. Cardiac myocytes constitutively exhibit a high-affinity Larginine transport system (K m ؍ 125 M; V max ؍ 44 pmol/2 ؋ 10 5 cells/min). Following a 24-h exposure to IL-1 and IFN␥, arginine uptake increases (V max ؍ 167 pmol/2 ؋ 10 5 cells/min) and a second low-affinity L-arginine transporter activity appears (K m ؍ 1.2 mM). To examine the molecular basis for these cytokine-induced changes in arginine transport, we examined expression of three related arginine transporters previously identified in other cell types. mRNA for the high-affinity cationic amino acid transporter-1 (CAT-1) is expressed in resting myocytes and steady-state levels increase by 10-fold following exposure to IL-1 and IFN␥. Only cytokine-pretreated myocytes expressed a second high-affinity L-arginine transporter, CAT-2B, as well as a lowaffinity L-arginine transporter, CAT-2A. In addition, insulin, which potentiated cytokine-dependent NO production independent of any change in NOS activity, increased myocyte L-arginine uptake by 2-fold and steadystate levels of CAT-1, but not CAT-2A or CAT-2B mRNA. Thus, NO production by cardiac myocytes exposed to IL-1 plus IFN␥ appears to be dependent on the coinduction of CAT-1, CAT-2A, and CAT-2B, while insulin independently augments L-arginine transport through CAT-1.
The inducible isoform of nitric oxide synthase (iNOS or
NOS2)1 is expressed in a wide variety of cell types including neonatal and adult cardiac myocytes after exposure to inflammatory mediators (1-6). Nitric oxide (NO) production by cardiac myocytes in vitro decreases spontaneous beating rate (a negative chronotropic effect) (5, 7) and the velocity and extent of shortening (a negative inotropic effect) (6 -12), and accelerates the velocity of re-lengthening (a positive lusitropic effect) (13,14). We recently demonstrated that cytokine-induced NO production by adult rat ventricular myocytes (ARVM), and its effect to diminish the inotropic responsiveness of these cells in vitro to the -adrenergic agonist isoproterenol, was insulin-dependent (15). The observation that this effect of insulin was not a consequence of changes in NOS activity suggested that insulin was affecting myocyte NO generation by additional mechanisms that were independent of the extent of increased expression and activity of NOS2 protein. Potential additional sites for regulating cellular NO production include the availability of intracellular arginine and NOS co-factors. Changes in ar...